|
1
|
Gansler T, Ganz PA, Grant M, Greene FL,
Johnstone P, Mahoney M, Newman LA, Oh WK, Thomas CR Jr, Thun MJ, et
al: Sixty years of CA: A cancer journal for clinicians. CA Cancer J
Clin. 60:345–350. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sinevici N and O'Sullivan J: Oral cancer:
Deregulated molecular events and their use as biomarkers. Oral
Oncol. 61:12–18. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Forastiere A, Koch W, Trotti A and
Sidransky D: Head and neck cancer. N Engl J Med. 345:1890–1900.
2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hatcher H, Planalp R, Cho J, Torti FM and
Torti SV: Curcumin: From ancient medicine to current clinical
trials. Cell Mol Life Sci. 65:1631–1652. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ammon HP and Wahl MA: Pharmacology of
curcuma longa. Planta Med. 57:1–7. 1991.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Aggarwal BB: Targeting
inflammation-induced obesity and metabolic diseases by curcumin and
other nutraceuticals. Annu Rev Nutr. 30:173–199. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sri Ramya PV, Guntuku L, Angapelly S,
Karri S, Digwal CS, Babu BN, Naidu VGM and Kamal A: Curcumin
inspired 2-chloro/phenoxy quinoline analogues: Synthesis and
biological evaluation as potential anticancer agents. Bioorg Med
Chem Lett. 28:892–898. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lelli D, Pedone C, Majeed M and Sahebkar
A: Curcumin and lung cancer: The role of microRNAs. Curr Pharm Des.
23:3440–3444. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Basha R, Connelly SF, Sankpal UT, Nagaraju
GP, Patel H, Vishwanatha JK, Shelake S, Tabor-Simecka L, Shoji M,
Simecka JW and El-Rayes B: Small molecule tolfenamic acid and
dietary spice curcumin treatment enhances antiproliferative effect
in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB
translocation to nucleus and cell cycle phase distribution. J Nutr
Biochem. 31:77–87. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chatterjee B, Ghosh K, Suresh L and Kanade
SR: Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase
expression by decreasing the Sp1 and NF-YA transcription factors in
the A549 and MCF-7 cells. Mol Cell Biochem. 455:73–90.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hassanalilou T, Ghavamzadeh S and Khalili
L: Curcumin and gastric cancer: A review on mechanisms of action. J
Gastrointest Cancer. 50:185–192. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang HH, Zhang Y, Cheng YN, Gong FL, Cao
ZQ, Yu LG and Guo XL: Metformin incombination with curcumin
inhibits the growth, metastasis, and angiogenesis of hepatocellular
carcinoma in vitro and in vivo. Mol Carcinog. 57:44–56.
2018.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Mohandas KM and Desai DC: Epidemiology of
digestive tract cancers in India V. Large and small bowel. Indian J
Gastroenterol. 18:118–121. 1999.PubMed/NCBI
|
|
14
|
Marquardt JU, Gomez-Quiroz L, Arreguin
Camacho LO, Pinna F, Lee YH, Kitade M, Domínguez MP, Castven D,
Breuhahn K, Conner EA, et al: Curcumin effectively inhibits
oncogenic NF-κB signaling and restrains stemness features in liver
cancer. J Hepatol. 63:661–669. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schwertheim S, Wein F, Lennartz K, Worm K,
Schmid KW and Sheu-Grabellus SY: Curcumin induces G2/M arrest,
apoptosis, NF-κB inhibition, and expression of differentiation
genes in thyroid carcinoma cells. J Cancer Res Clin Oncol.
143:1143–1154. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang Y, Hu L, Huang S, Xu W, Wan J, Wang
D, Zheng G and Xia Z: Curcumin-loaded galactosylated BSA
nanoparticles as targeted drug delivery carriers inhibit
hepatocellular carcinoma cell proliferation and migration. Int J
Nanomedicine. 13:8309–8323. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang D, Veena MS, Stevenson K, Tang C, Ho
B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES and Wang MB:
Liposome-encapsulated curcumin suppresses growth of head and neck
squamous cell carcinoma in vitro and in xenografts through the
inhibition of nuclear factor kappaB by an AKT-independent pathway.
Clin Cancer Res. 14:6228–6236. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shi Q, Le X, Abbruzzese JL, Peng Z, Qian
CN, Tang H, Xiong Q, Wang B, Li XC and Xie K: Constitutive Sp1
activity is essential for differential constitutive expression of
vascular endothelial growth factor in human pancreatic
adenocarcinoma. Cancer Res. 61:4143–4154. 2001.PubMed/NCBI
|
|
19
|
Abdelrahim M, Smith R III, Burghardt R and
Safe S: Role of Sp proteins in regulation of vascular endothelial
growth factor expression and proliferation of pancreatic cancer
cells. Cancer Res. 64:6740–6749. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and kruppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Safe S and Abdelrahim M: Sp transcription
factor family and its role in cancer. Eur J Cancer. 41:2438–2448.
2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hu H, Wu LL, Han T, Zhuo M, Lei W, Cui JJ,
Jiao F and Wang LW: Correlated high expression of FXR and Sp1 in
cancer cells confers a poor prognosis for pancreatic cancer: A
study based on TCGA and tissue microarray. Oncotarget.
8:33265–33275. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jiang W, Jin Z, Zhou F, Cui J and Wang L
and Wang L: High co-expression of Sp1 and HER-2 is correlated with
poor prognosis of gastric cancer patients. Surg Oncol. 24:220–225.
2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Su CW, Chang YC, Chien MH, Hsieh YH, Chen
MK, Lin CW and Yang SF: Loss of TIMP3 by promoter methylation of
Sp1 binding site promotes oral cancer metastasis. Cell Death Dis.
10(793)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yu HJ, Shin JA, Nam JS, Kang BS and Cho
SD: Apoptotic effect of dibenzylideneacetone on oral cancer cells
via modulation of specificity protein 1 and Bax. Oral Dis.
19:767–774. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cho JH, Shin JC, Cho JJ, Choi YH, Shim JH
and Chae JI: Esculetin (6,7-dihydroxycoumarin): A potential cancer
chemopreventive agent through suppression of Sp1 in oral squamous
cancer cells. Int J Oncol. 46:265–271. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jeon YJ, Bang W, Choi YH, Shim JH and Chae
JI: Beta-lapachone suppresses non-small cell lung cancer
proliferation through the regulation of specificity protein 1. Biol
Pharm Bull. 38:1302–1308. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jeon YJ, Bang W, Shin JC, Park SM, Cho JJ,
Choi YH, Seo KS, Choi NJ, Shim JH and Chae JI: Downregulation of
Sp1 is involved in β-lapachone-induced cell cycle arrest and
apoptosis in oral squamous cell carcinoma. Int J Oncol.
46:2606–2612. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim DW, Ko SM, Jeon YJ, Noh YW, Choi NJ,
Cho SD, Moon HS, Cho YS, Shin JC, Park SM, et al:
Anti-proliferative effect of honokiol in oral squamous cancer
through the regulation of specificity protein 1. Int J Oncol.
43:1103–1110. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gao Z, Zhang Y, Zhou H and Lv J: Baicalein
inhibits the growth of oral squamous cell carcinoma cells by
downregulating the expression of transcription factor Sp1. Int J
Oncol. 56:273–282. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Banerjee S, Sangwan V, McGinn O, Chugh R,
Dudeja V, Vickers SM and Saluja AK: Triptolide-induced cell death
in pancreatic cancer is mediated by O-GlcNAc modification of
transcription factor Sp1. J Biol Chem. 288:33927–33938.
2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chiang IT, Liu YC, Hsu FT, Chien YC, Kao
CH, Lin WJ, Chung JG and Hwang JJ: Curcumin synergistically
enhances the radiosensitivity of human oral squamous cell carcinoma
via suppression of radiation-induced NF-κB activity. Oncol Rep.
31:1729–1737. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dudás J, Fullar A, Romani A, Pritz C,
Kovalszky I, Hans Schartinger V, Mathias Sprinzl G and Riechelmann
H: Curcumin targets fibroblast-tumor cell interactions in oral
squamous cell carcinoma. Exp Cell Res. 319:800–809. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jiang L and Xiao J:
2-phenylethynesulfonamide inhibits growth of oral squamous cell
carcinoma cells by blocking the function of heat shock protein 70.
Biosci Reps. 40(BSR20200079)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang Y, Wang H, Liu Y, Wang C, Wang J,
Long C, Guo W and Sun X: Baicalein inhibits growth of Epstein-Barr
virus-positive nasopharyngeal carcinoma by repressing the activity
of EBNA1 Q-promoter. Biomed Pharmacothe. 102:1003–1014.
2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Newman DJ, Cragg GM and Snader KM: Natural
products as sources of new drugs over the period 1981-2002. J Nat
Prod. 66:1022–1037. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhang Q, Qiao H, Wu D, Lu H, Liu L, Sang
X, Li D and Zhou Y: Curcumin potentiates the galbanic acid-induced
anti-tumor effect in non-small cell lung cancer cells through
inhibiting Akt/mTOR signaling pathway. Life Sci.
239(117044)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li W, Wang Z, Xiao X, Han L, Wu Z, Ma Q
and Cao L: Curcumin attenuates hyperglycemia-driven EGF-induced
invasive and migratory abilities of pancreatic cancer via
suppression of the ERK and AKT pathways. Oncol Rep. 41:650–658.
2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Pereira MC, Mohammed R, Van Otterlo WAL,
De Koning CB and Davids H: In vitro analysis of the combinatory
effects of novel aminonaphthoquinone derivatives and curcumin on
breast cancer progression. Anticancer Res. 40:229–238.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Tian M, Tian D, Qiao X, Li J and Zhang L:
Modulation of Myb-induced NF-kB-STAT3 signaling and resulting
cisplatin resistance in ovarian cancer by dietary factors. J Cell
Physiol. 234:21126–21134. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Boven L, Holmes SP, Latimer B, McMartin K,
Ma X, Moore-Medlin T, Khandelwal AR, McLarty J and Nathan CO:
Curcumin gum formulation for prevention of oral cavity head and
neck squamous cell carcinoma. Laryngoscope. 129:1597–1603.
2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF,
Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, et al: Phase I
clinical trial of curcumin, a chemopreventive agent, in patients
with high-risk or pre-malignant lesions. Anticancer Res.
21:2895–2900. 2001.PubMed/NCBI
|
|
44
|
Kanai M, Yoshimura K, Asada M, Imaizumi A,
Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y,
et al: A phase I/II study of gemcitabine-based chemotherapy plus
curcumin for patients with gemcitabine-resistant pancreatic cancer.
Cancer Chemother Pharmacol. 68:157–164. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Bayet-Robert M, Kwiatkowski F, Leheurteur
M, Gachon F, Planchat E, Abrial C, Mouret-Reynier MA, Durando X,
Barthomeuf C and Chollet P: Phase I dose escalation trial of
docetaxel plus curcumin in patients with advanced and metastatic
breast cancer. Cancer Biol Ther. 9:8–14. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Monisha J, Roy NK, Bordoloi D, Kumar A,
Golla R, Kotoky J, Padmavathi G and Kunnumakkara AB: Nuclear factor
Kappa B: A potential target to persecute head and neck cancer. Curr
Drug Targets. 18:232–253. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Tang D, Tao D, Fang Y, Deng C, Xu Q and
Zhou J: TNF-alpha promotes invasion and metastasis via NF-Kappa B
pathway in oral squamous cell carcinoma. Med Sci Monit Basic Res.
23:141–149. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Bond M, Fabunmi RP, Baker AH and Newby AC:
Synergistic upregulation of metalloproteinase-9 by growth factors
and inflammatory cytokines: An absolute requirement for
transcription factor NF-kappa B. FEBS Lett. 435:29–34.
1998.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Alam M, Kashyap T, Pramanik KK, Singh AK,
Nagini S and Mishra R: The elevated activation of NFκB and AP-1 is
correlated with differential regulation of Bcl-2 and associated
with oral squamous cell carcinoma progression and resistance. Clin
Oral Investig. 21:2721–2731. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yoshida K, Sasaki R, Nishimura H, Okamoto
Y, Suzuki Y, Kawabe T, Saito M, Otsuki N, Hayashi Y, Soejima T, et
al: Nuclear factor-kappaB expression as a novel marker of
radioresistance in Early-stage laryngeal cancer. Head Neck.
32:646–655. 2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Yang SH, Hsu CH, Lee JC, Tien YW, Kuo SH
and Cheng AL: Nuclear expression of glioma-associated oncogene
homolog 1 and nuclear factor-κB is associated with a poor prognosis
of pancreatic cancer. Oncology. 85:86–94. 2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Jiang LZ, Wang P, Deng B, Huang C, Tang
WX, Lu HY and Chen HY: Overexpression of forkhead box M1
transcription factor and nuclear factor-κB in laryngeal squamous
cell carcinoma: A potential indicator for poor prognosis. Hum
Pathol. 42:1185–1193. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Qiao Q, Jiang Y and Li G: Curcumin
improves the antitumor effect of X-ray irradiation by blocking the
NF-κB pathway: An in-vitro study of lymphoma. Anticancer Drugs.
23:597–605. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Teymouri M, Pirro M, Johnston TP and
Sahebkar A: Curcumin as a multifaceted compound against human
papilloma virus infection and cervical cancers: A review of
chemistry, cellular, molecular, and preclinical features.
Biofactors. 43:331–346. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Shin HK, Kim J, Lee EJ and Kim SH:
Inhibitory effect of curcumin on motility of human oral squamous
carcinoma YD-10B cells via suppression of ERK and NF-kappaB
activations. Phytother Res. 24:577–582. 2010.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Shin JA, Kim JJ, Choi ES, Shim JH, Ryu MH,
Kwon KH, Park HM, Seo JY, Lee SY, Lim DW, et al: In vitro apoptotic
effects of methanol extracts of dianthus chinensis and Acalypha
australis L targeting specificity protein 1 in human oral cancer
cells. Head Neck. 35:992–998. 2013.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Sachita K, Yu HJ, Yun JW, Lee JS and Cho
SD: YM155 induces apoptosis through downregulation of specificity
protein 1 and myeloid cell leukemia-1 in human oral cancer cell
lines. J Oral Pathol Med. 44:785–791. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Hsieh MJ, Chen JC, Yang WE, Chien SY, Chen
MK, Lo YS, His YT, Chuang YC, Lin CC and Yang SF:
Dehydroandrographolide inhibits oral cancer cell migration and
invasion through NF-κB-, AP-1-, and SP-1-modulated matrix
metalloproteinase-2 inhibition. Biochem Pharmacol. 130:10–20.
2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Chen P, Huang HP, Wang Y, Jin J, Long WG,
Chen K, Zhao XH, Chen CG and Li J: Curcumin overcome primary
gefitinib resistance in non-small-cell lung cancer cells through
inducing autophagy-related cell death. J Exp Clin Cancer Res.
38(254)2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Lima FT, Seba V, Silva G, Torrezan GS,
Polaquini CR, Pinhanelli VC, Baek SJ, Fachin AL, Regasini LO and
Marins M: The curcumin analog CH-5 exerts anticancer effects in
human osteosarcoma cells via modulation of transcription factors
p53/Sp1. Int J Mol Sci. 19(1909)2018.PubMed/NCBI View Article : Google Scholar
|
